Articles Archives - Page 247 of 733

MondayAug 29, 2022 11:15 am

Friendable Inc. (FDBL) Addresses Churn in the Music Streaming Industry by Offering Fan Pass Live and Branded Products to Enhance Listener Experience

Churn occurs when subscribers sign up for a streaming service and immediately cancel once the current season or event is over, but re-sign up when something new catches their attention Fan Pass Live offers subscribers a new type of experience that revolves around the life of their favorite artists and the ability to see them on-demand The global music streaming industry was valued at $29.49 billion in 2021 and is expected to reach $103.07 billion by 2030, growing at a CAGR of 14.7% For companies competing in the music and video streaming industry, personalization is becoming a key contributor to…

MondayAug 29, 2022 10:30 am

FuelPositive Corp. (TSX.V: NHHH) (OTCQB: NHHHF) Supporting Best Farming Practices to Reduce Agriculture-Related Greenhouse Gas Emissions, Ammonia Emissions

FuelPositive is a growth-stage company focused on developing clean energy solutions such as its onsite, containerized green ammonia production system FuelPositive understands the impact of ammonia emissions on the environment and biodiversity and is supporting best farming practices that are geared toward eliminating the production, storage, and spreading of manure, a significant source of the emissions The company’s system generates green ammonia, which can be injected deep into the soil, reducing the possibility of volatilization (the process through which gaseous ammonia is emitted into the atmosphere) The company is working towards helping farmers solve on-farm nitrogen emissions, having already tackled…

MondayAug 29, 2022 9:45 am

With a Fresh $31 Million in Tow, EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQB: EVGIF) to Ramp RNG Supply Across Canada

EverGen owns and operates Western Canada’s original renewable natural gas facility and is expanding nationwide EverGen already has existing offtake agreements with FortisBC, part of the nation’s largest private utility EverGen recently signed a new loan agreement providing $31 million for expansion at its flagship projects in B.C. Renewable Natural Gas, or RNG, is instrumental in meeting emissions targets by taking methane-producing organic feedstock like disposed food, sewage water, and animal waste and converting it into a carbon-neutral products, including an alternative to traditional natural gas. FortisBC Energy is a climate control steward in Western Canada, ramping supply agreements with…

MondayAug 29, 2022 9:00 am

AROYA Crop Steering Expertise and Technology Provides Data-Driven Insights, Automation and Competitive Advantage for Successful Harvests

For cannabis operators, crop steering directs how their plants grow as well as their literal shape. Knowing how and when to manipulate light, climate and irrigation – the three foundational components of crop steering – is essential to balancing high yields and high quality. Why do successful growers – from small craft farmers to the largest multistate operators – use data-driven and automated crop steering solutions? Because even the slightest adjustments to any number of factors can have huge effects on grows. Data is the lifeblood of a plant growers, providing the intelligence to track how and when plants change…

FridayAug 26, 2022 12:00 pm

Hillcrest Energy Technologies Ltd.’s (CSE: HEAT) (OTCQB: HLRTF) (FRA: 7HIA) Power Inverter Platform Boosts Performance and Efficiency, Enables Multiple End-Uses

Hillcrest’s power inverter technology platform to offer efficiency and performance improvements Hillcrest inverter technology platform can be applied at nearly every stage of the electric ecosystem Electrification is playing a prominent role in the global transition from fossil fuels to sustainable energy sources. As energy costs rise amid increased demand, Hillcrest Energy Technologies (CSE: HEAT) (OTCQB: HLRTF) (FRA: 7HIA.F) holds a vital key that unlocks performance and efficiency improvements throughout the entire electrification ecosystem. Hillcrest’s first application for its inverter technology is focused on the growing EV market. Hillcrest’s SiC high-efficiency traction inverter technology converts the DC output from the…

FridayAug 26, 2022 11:15 am

Lexaria Bioscience Corp.’s (NASDAQ: LEXX) Drug Development Program and Recent FDA Confirmation Position It for Favorable Valuation

Lexaria is a global innovator of drug delivery platforms, including its patented DehydraTECH(TM) technology The company recently released information that would help its stakeholders research and understand how biotech and pharmaceutical companies are valued Based on some of the methodologies used in valuation, Lexaria is positioned favorably as its DehydraTECH-processed CBD for the treatment of hypertension has successfully reached the IND application stage, with the program recently receiving an additional boost The FDA agreed with Lexaria’s proposal to pursue a 505(b)(2) new drug application (“NDA”) regulatory pathway, an abbreviated pathway, for its hypertension program As a follow-up to recent coverage…

FridayAug 26, 2022 10:30 am

Laredo Oil Inc. (LRDC) Progressing Toward Drilling as 2023 Oil Demand Projected to Increase

OPEC releases “bullish” forecast for oil demand moving into 2023 Healthy global economic growth, improvements in geopolitical developments and containment of COVID-19 in China contribute to positive projection LRDC has leased 37,900 mineral acres in the Western Williston Basin of Montana Despite a slowing economy and worries of a recession, the oil and gas industry has rebounded strongly throughout 2021, with oil prices reaching their highest levels in six years, a recent Deloitte report noted (https://ibn.fm/aobNZ); OPEC’s recent bullish 2023 forecast indicates that upward trend may continue. That’s good news for Laredo Oil (OTC: LRDC), an oil exploration and production…

FridayAug 26, 2022 9:45 am

Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Leading Out in Transformation of Psychedelic Sector

Psilocybin is seeing a “research resurgence” focused on how the substance changes the brain's connectivity patterns CYBN is leading the industry in developing proprietary psychedelic-based therapeutics The company’s lead investigational molecule has the potential to treat major depressive disorder and alcohol use disorder The status of psilocybin is evolving as a result of mounting public acceptance and growing evidence that the substance delivers remarkable health benefits. Cybin (NEO: CYBN) (NYSE American: CYBN) is on the leading edge of this transformation, as the clinical-stage biopharmaceutical company focuses on progressing psychedelics to therapeutics by offering a new standard of care for mental-health disorders…

FridayAug 26, 2022 9:00 am

Golden Matrix Group Inc. (NASDAQ: GMGI) Scores Big Q3 Win on International Expansion

GMGI sets new bar for quarterly revenue, topping $9 million for first time The company currently has a string of 15 consecutive profitable quarters Golden Matrix is growing through international M&A activity and launching gaming products, including a new highly anticipated eSports platform Tech stocks have rallied since the tech-laden Nasdaq hit a nearly two-year low in June. Most of the first half of the year was dominated by geopolitical drama, and international upheaval fueling recession concerns amid spiking inflation. None of that stopped Golden Matrix Group (NASDAQ: GMGI) from having its best revenue quarter ever, spearheaded by horizontal and…

ThursdayAug 25, 2022 10:30 am

Phase I Trial Advance for Concussion Drug Leads Odyssey Health, Inc. (ODYY) to Prepare to Launch the Efficacy Analysis Stage for its Product

Brain concussion injuries have commanded a new level of respect in recent years as military personnel, athletes and care center administrations seek remedies rather than simply encouraging people to “shake off” a hard hit to the head Odyssey Health is advancing clinical trials for its novel PRV-002 drug / device solution for treating concussion patients The company reported completion of four cohorts of testing for safety in human subjects in August, and is preparing to launch Phase II testing that will evaluate the product’s efficacy PRV-002 is administered intranasally where it can be taken up across the blood-brain barrier by…

Site Search

Company Search

Category: Articles